EntryPoint Capital LLC Takes $306,000 Position in Grail, Inc. (NASDAQ:GRAL)

EntryPoint Capital LLC purchased a new stake in Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 17,153 shares of the company’s stock, valued at approximately $306,000. EntryPoint Capital LLC owned 0.05% of Grail at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. FNY Investment Advisers LLC bought a new stake in shares of Grail during the 4th quarter valued at $26,000. Lindbrook Capital LLC acquired a new position in Grail in the fourth quarter valued at about $28,000. Wellington Shields Capital Management LLC bought a new stake in Grail during the fourth quarter worth about $33,000. New York State Common Retirement Fund acquired a new stake in Grail during the fourth quarter worth about $59,000. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Grail during the fourth quarter worth about $64,000.

Wall Street Analyst Weigh In

Separately, Morgan Stanley upped their price target on shares of Grail from $16.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th.

Grail Trading Up 0.7 %

Shares of GRAL opened at $28.58 on Friday. Grail, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99. The business’s fifty day moving average is $33.84 and its 200-day moving average is $22.26.

Grail (NASDAQ:GRAL) last released its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. Research analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Insider Activity at Grail

In other Grail news, CFO Aaron Freidin sold 1,816 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the sale, the chief financial officer now owns 335,170 shares of the company’s stock, valued at approximately $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Joshua J. Ofman sold 2,109 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares of the company’s stock, valued at $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,550 shares of company stock valued at $360,436.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.